SCHEMBL6172313

SCHEMBL6172313

CCCc1ccnc(C(C)=O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.44
▸ SMYD3 Q9H7B4 1/20 0.40
▸ CNR1 P21554 1/20 0.39
▸ CNR2 P34972 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ HTT P42858 1/20 0.39
▸ MAPT P10636 3/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ NR2F2 P24468 1/20 0.38
▸ PAX8 Q06710 1/20 0.38
▸ KLF5 Q13887 1/20 0.38
▸ NR3C2 P08235 3/20 0.37
▸ KDM5A P29375 2/20 0.37
▸ KDM5B Q9UGL1 2/20 0.37
▸ LOXL2 Q9Y4K0 1/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ LMNA P02545 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ TSHR P16473 2/20 0.37
▸ PLK1 P53350 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4863083 0.86 ALDH1A1 (0.52) ALDH1A1SMYD3CNR1CNR2SMN1; SMN2
SCHEMBL13813279 0.86 ALDH1A1 (0.44) ALDH1A1SMYD3SMN1; SMN2MAPTL3MBTL1
SCHEMBL6173009 0.85 SMYD3 (0.51) ALDH1A1SMYD3MAPTL3MBTL1KDM5A
Hydrochloric Acid SCHEMBL971588 0.84 ALDH1A1 (0.50) ALDH1A1SMYD3SMN1; SMN2HTTMAPT
SCHEMBL16594468 0.84 NR2F2 (0.43) SMYD3SMN1; SMN2HTTNR2F2PAX8
SCHEMBL1167120 0.81 RECQL (0.50) ALDH1A1SMYD3SMN1; SMN2MAPTL3MBTL1
SCHEMBL3129887 0.81 ALDH1A1 (0.41) ALDH1A1SMYD3NR3C2LOXL2LMNA
SCHEMBL13945543 0.81 PLK1 (0.51) SMYD3SMN1; SMN2HTTLOXL2PLK1
SCHEMBL12315306 0.81 ALDH1A1 (0.43) ALDH1A1SMYD3SMN1; SMN2MAPTL3MBTL1
SCHEMBL14353399 0.80 FAAH (0.42) ALDH1A1HTTMAPTL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 — — EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 — — US disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 — — EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 — — WO disclosed
Send feedback